Solasto Corporation

Tokyo Stock Exchange 6197.T

Solasto Corporation EBITDA for the year ending March 31, 2024: USD 51.34 M

Solasto Corporation EBITDA is USD 51.34 M for the year ending March 31, 2024, a -27.91% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Solasto Corporation EBITDA for the year ending March 31, 2023 was USD 71.22 M, a -2.77% change year over year.
Solasto Corporation EBITDA for the year ending March 31, 2022 was USD 73.25 M, a -3.44% change year over year.
Solasto Corporation EBITDA for the year ending March 31, 2021 was USD 75.86 M, a 10.01% change year over year.
Solasto Corporation EBITDA for the year ending March 31, 2020 was USD 68.96 M, a 16.86% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Tokyo Stock Exchange: 6197.T

Solasto Corporation

CEO	Mr. Toru Noda
IPO Date	June 29, 2016
Location	Japan
Headquarters	1-7-18 Konan
Employees	33,884
Sector	Industrials
Industries Professional Services Hospitals & Clinics

Description

Solasto Corporation provides medical outsourcing services primarily to medical institutions in Japan. The company's medical outsourcing services include contracted services of medical clerical work. It also offers elderly care services, such as day service, home help, facility-based service, etc.; and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years